GENEVA–(BUSINESS WIRE)–Alcon Publishes Agenda for 2023 Annual General Meeting
Author: Business Wire
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., …
Global Dry Eye Disease Market Size, Share, Growth Analysis, By Product, By Distribution Channel – Industry Forecast 2022-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Disease Market Size, Share, Growth Analysis, By Product, By Distribution Channel – Industry Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Global dry eye disease market size …
Harrow Announces New $100 Million Secured Credit Facility with Oaktree
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it has entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Manageme…
OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)– #AMD–OliX Pharmaceuticals announces the Phase 1 clinical trial of OLX10212, an investigational RNAi for the treatment of age-related macular degenerations.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal Endothelial Cell Substitute (CLS001)
TOKYO–(BUSINESS WIRE)–Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at the 22nd Japanese Society for Regen…
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
GENEVA–(BUSINESS WIRE)–Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after market close on Thursday, March 30, 2023 and will hold an…
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech Receives Regulatory Approval from Japan’s PMDA for its Cell Therapy to Treat Corneal Endothelial Disease
Visus Therapeutics Completes Enrollment in BRIO-I, a Phase 3 Clinical Trial of BRIMOCHOL™ PF for the Treatment of Presbyopia
SEATTLE & IRVINE, Calif.–(BUSINESS WIRE)– #VisusTx–Visus Therapeutics announced it completed enrollment in BRIO-I, a pivotal Phase 3 clinical trial of BRIMOCHOL™ PF for the treatment of presbyopia.
Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology
VAUGHAN, Ontario & HEIDELBERG, Germany–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical comp…
OcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal. By assessing the fl…
Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022
SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and care coordination, today announced it has been named one of Fierce Medtech’s “Fierce 15 Medtech Companies of 2022,” designating it as one of the most promising…
Anthem Blue Cross Helps Health Centers in Underserved Regions of California Offer Specialty Healthcare Services to Uninsured Patients
FRESNO, Calif.–(BUSINESS WIRE)—- $Anthem #Alpine–Anthem Blue Cross provides grant that enables uninsured Californians to access healthcare from specialists.
Alcon to Host 2023 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2023 Capital Markets Day
Alcon to Host 2023 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2023 Capital Markets Day
Aviceda Announces Successful Submission of an Investigational New Drug (IND) and Fast Track Designation (FTD) Application for AVD-104 for the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration (AMD)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modulate the innate immune system and alleviate chronic, non-resol…
RG6501 (OpRegen®) Phase 1/2a Clinical Results to Be Presented at 2023 Retinal Cell and Gene Therapy Innovation Summit
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease
LITTLE ROCK, Ark.–(BUSINESS WIRE)–Kuria Therapeutics, a pharmaceutical company developing novel ophthalmic and dermal therapeutics, is pleased to announce it has completed a pre-Investigational New Drug (“IND”) interaction with the U.S. Food and Drug…
HPO, in Collaboration with Eastman, Announces Upcoming Launch of High Energy Visible Light Filtering Film in the Transportation Space
CHARLOTTE, N.C.–(BUSINESS WIRE)–Eastman and High Performance Optics, Inc. (HPO) announced today that a selective High Energy Visible Light (HEVL) filtering window film for the transportation industry will be launched in Asia. Selective HEVL filtering…